Business
AstraZeneca advice unlikely to change despite rate of rare clotting ‘doubling’ – Sydney Morning Herald
New European research suggests the incidence of a rare blood clotting condition in AstraZeneca vaccine recipients is twice as prevalent as previously reported,…
Professor Cheng said incidence of cases reported from Europe was still a pretty small number and possibly a result of doctors getting better at detecting the condition, which has a fatality rate of about one in four cases.
Im sure very early on, before anyone realised what this was, people thought it was just an unusual clot there may have been some that flew under the radar, he said.
ATAGI issued an advisory in early April recommending people under 50 receive the Pfizer vaccine ahead of the AstraZeneca…
-
Noosa News22 hours agoTributes for woman allegedly mowed down on footpath in Maroochydore; Guilherme Dal Bo charged
-
General19 hours agoMan refused bail charged with depicting Adolf Hitler and Nazi symbols on boat
-
General15 hours agoTwo people arrested after man fatally shot at McLaren Flat
-
General13 hours agoWarner Bros Discovery board rejects rival $163bn bid from Paramount